240 related articles for article (PubMed ID: 37835461)
41. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
[TBL] [Abstract][Full Text] [Related]
42. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
43. Acute Promyelocytic Leukemia in Children: A Single Centre Experience from Turkey.
Aksu T; Fettah A; Bozkaya İO; Baştemur M; Kara A; Çulha VK; Özbek NY; Yaralı N
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018045. PubMed ID: 30002801
[TBL] [Abstract][Full Text] [Related]
44. [Therapies for newly diagnosed acute promyelocytic leukemia].
Yokoyama Y
Rinsho Ketsueki; 2020; 61(9):1166-1173. PubMed ID: 33162512
[TBL] [Abstract][Full Text] [Related]
45. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.
Sanz MA; Montesinos P
Blood; 2014 May; 123(18):2777-82. PubMed ID: 24627526
[TBL] [Abstract][Full Text] [Related]
46. Aleukemic Acute Promyelocytic Leukemia: How Concomitant HIV, Hepatitis C, and Chronic Alcohol Use Disorder May Have Hidden an Underlying Malignancy.
Mahmoud A; Ghrewati M; Kania B; Naseer M; Kapoor A; Michael P
Am J Case Rep; 2023 Feb; 24():e938086. PubMed ID: 36760096
[TBL] [Abstract][Full Text] [Related]
47. Recurrent differentiation syndrome or septic shock? Unresolved dilemma in a patient with acute promyelocytic leukemia.
Jeddi R; Ghédira H; Amor RB; Menif S; Belhadjali Z; Meddeb B
Med Oncol; 2011 Mar; 28(1):279-81. PubMed ID: 20204541
[TBL] [Abstract][Full Text] [Related]
48. Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120.
Birendra KC; DiNardo CD
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):460-5. PubMed ID: 27245312
[TBL] [Abstract][Full Text] [Related]
49. Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.
Geer MJ; Foucar CE; Devata S; Benitez L; Perissinotti AJ; Marini BL; Bixby D
J Natl Compr Canc Netw; 2021 Aug; 19(11):1272-1275. PubMed ID: 34404029
[TBL] [Abstract][Full Text] [Related]
50. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
[TBL] [Abstract][Full Text] [Related]
51. Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.
Falanga A; Russo L; Tartari CJ
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011068. PubMed ID: 22220265
[TBL] [Abstract][Full Text] [Related]
52. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)).
Küley-Bagheri Y; Kreuzer KA; Monsef I; Lübbert M; Skoetz N
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011960. PubMed ID: 30080246
[TBL] [Abstract][Full Text] [Related]
53. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Montesinos P; Bergua JM; Vellenga E; Rayón C; Parody R; de la Serna J; León A; Esteve J; Milone G; Debén G; Rivas C; González M; Tormo M; Díaz-Mediavilla J; González JD; Negri S; Amutio E; Brunet S; Lowenberg B; Sanz MA
Blood; 2009 Jan; 113(4):775-83. PubMed ID: 18945964
[TBL] [Abstract][Full Text] [Related]
54. Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration.
Nauffal M; Werner L; Ni J; Stone RM; DeAngelo DJ; McDonnell AM
Leuk Res Rep; 2019; 12():100189. PubMed ID: 31867205
[TBL] [Abstract][Full Text] [Related]
55. HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells.
Tang L; Chai W; Ye F; Yu Y; Cao L; Yang M; Xie M; Yang L
Oncotarget; 2017 Apr; 8(16):27314-27327. PubMed ID: 28404891
[TBL] [Abstract][Full Text] [Related]
56. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.
Özpolat B
Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273
[TBL] [Abstract][Full Text] [Related]
57. Sustained remission achieved with ATRA and chemotherapy in second relapse of acute promyelocytic leukemia in Down syndrome.
Ghosh I; Kumar L; Seth R; Thavraj V
J Pediatr Hematol Oncol; 2009 Aug; 31(8):539-40. PubMed ID: 19636277
[TBL] [Abstract][Full Text] [Related]
58. [Therapy-related myeloid neoplasms after successful treatment for acute promyelocytic leukemia: a report of four cases and literature review].
Wang Z; Xu MZ; Chen YF; Xue F; Zhang L; Hu YM; Li CW; Li SZ; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1008-1014. PubMed ID: 32023731
[No Abstract] [Full Text] [Related]
59. The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role of hematopoietic stem cell transplantation in acute promyelocytic leukemia.
Nagai S; Takahashi T; Kurokawa M
Curr Stem Cell Res Ther; 2010 Dec; 5(4):372-8. PubMed ID: 20528759
[TBL] [Abstract][Full Text] [Related]
60. Pancreatitis in Acute Promyelocytic Leukemia: Drug-induced or Differentiation Syndrome?
De D; Nath UK; Chakrabarti P
Indian J Med Paediatr Oncol; 2017; 38(3):371-373. PubMed ID: 29200694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
